Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Keratosis, Actinic 25 Uterine Cervical Dysplasia 13 Melanoma 10 Carcinoma, Basal Cell 10 Glioma 6 Glioblastoma 6 Breast Neoplasms 5 Uterine Cervical Neoplasms 4 Neoplasm Metastasis 4 Condylomata Acuminata 4 Precancerous Conditions 3 Papillomavirus Infections 3 Keratosis 3 Hutchinson's Melanotic Freckle 3 Vulvar Neoplasms 2 Urinary Bladder Neoplasms 2 Squamous Intraepithelial Lesions 2 Non-Muscle Invasive Bladder Neoplasms 2 Neoplasms 2 Hemangioma, Capillary 2 HIV Infections 2 Ependymoma 2 Colorectal Neoplasms 2 Brain Neoplasms 2 Astrocytoma 2 Warts 1 Vulvar High Grade Squamous Intraepithelial Lesion (HSIL) 1 Virus Diseases 1 Vaginal Neoplasms 1 Stomach Neoplasms 1

Interventions

pembrolizumab 23 Nivolumab 22 aldesleukin 21 Cyclophosphamide 20 Ipilimumab 17 Interleukin-2 17 fludarabine 15 fludarabine phosphate 14 cemiplimab 12 Radiotherapy 7 Fluorouracil 7 Dacarbazine 6 binimetinib 5 Vemurafenib 5 Temozolomide 5 Surgical Procedures, Operative 5 Sirolimus 5 Radiation 5 Biopsy 5 Aminolevulinic Acid 5 encorafenib 4 dabrafenib 4 Photochemotherapy 4 Educational Status 4 trametinib 3 sonidegib 3 montanide ISA 51 3 avelumab 3 Tacrolimus 3 Sodium Chloride 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Skin Neoplasms × Imiquimod × Clear all

NCT03534947 2025-12-16

SONIB

Melanoma Institute Australia

Phase 2 Completed

Carcinoma, Basal Cell, Skin Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡